Koo Ki Yeon, Moon Kwanho, Song Hwa Seob, Lee Min-Sik
Department of Life Sciences, POSTECH, Pohang, Korea.
Department of Life Sciences, POSTECH, Pohang, Korea.
Mol Cells. 2025 Apr;48(4):100198. doi: 10.1016/j.mocell.2025.100198. Epub 2025 Feb 20.
The tumor suppressor p53, long known for its roles in maintaining genomic integrity and suppressing tumorigenesis, has recently been recognized as a key regulator of cellular metabolism. Here, we review p53's emerging metabolic functions, highlighting its ability to orchestrate glucose, amino acid, and lipid metabolism. By promoting oxidative phosphorylation while inhibiting glycolysis and anabolic pathways, wild-type p53 counters metabolic reprogramming characteristic of cancer cells, such as the Warburg effect, and protects cells from mild cellular stresses. In contrast, mutant p53 disrupts these processes, fostering metabolic adaptations that support tumor progression. These findings pave the way for therapeutic approaches targeting p53-driven metabolic vulnerabilities in cancer.
肿瘤抑制因子p53长期以来因其在维持基因组完整性和抑制肿瘤发生方面的作用而闻名,最近它被认为是细胞代谢的关键调节因子。在此,我们综述p53新出现的代谢功能,重点介绍其协调葡萄糖、氨基酸和脂质代谢的能力。野生型p53通过促进氧化磷酸化同时抑制糖酵解和合成代谢途径,对抗癌细胞特有的代谢重编程,如瓦伯格效应,并保护细胞免受轻度细胞应激。相比之下,突变型p53会破坏这些过程,促进支持肿瘤进展的代谢适应。这些发现为针对癌症中p53驱动的代谢弱点的治疗方法铺平了道路。